Henan Taloph Pharmaceutical Stock Co.,Ltd

¥6.48As of Sun 8 Nov 2026, 12:00 UTC
SSE:600222Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR (2.39%)
Div yield 0.22%
ROE 3.37%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.81
PE TTM 70.32
TSR TTM 0.83%
Mkt cap ¥3.489B
ROIC 3.73%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥6.72
3.68%
(83.00%)
Hold 3|10|8|1|7
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.12
0.12
0.14
0.15
26.68%
30.66%
38.41%
35.69%
Revenue¥M
191.8
196.6
207.3
204.0
8.43%
10.74%
11.54%
9.45%
Peers (US$523.0M)
Cap (US$)
PE
524.0M
31.37x
518.3M
27.02x
Capital
TTM
5Y
10Y
Leveragex
2.777
(0.019)
(0.021)
EBIT/Intx
2.019
0.072
0.064
Own earn%
548.41
133.89
109.16
Sh yield%
43.26
31.15
30.08
Owners
Insiders/Inst%
1.30
50.61
Short interest%
5.12
SBC / revenue%
1.05
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
8
Op margin range%
2–10
$1 testx
—
Incr. ROIC%
14